Literature DB >> 20186177

Screening for chronic kidney disease in Australia: a pilot study in the community and workplace.

Timothy H Mathew1, Olivia Corso, Marie Ludlow, Adam Boyle, Alan Cass, Steven J Chadban, Beres Joyner, Mark Shephard, Tim Usherwood.   

Abstract

The pilot program Kidney Evaluation for You (KEY) was conducted in Australia to screen for chronic kidney disease (CKD). Targeting people at high risk (those with diabetes, hypertension, a first-degree relative with kidney failure, or age >50 years), KEY aimed to establish community-based screening protocols, assess efficacy in promoting changes in risk-factor management, and explore participant CKD awareness. KEY offered free cardiovascular and kidney checks using point-of-care testing for on-site pathology measurements (estimated glomerular filtration rate, hemoglobin A1c, cholesterol, hemoglobin, albuminuria), lifestyle assessment, and exit interviews. Participants were telephoned at 3 months to ascertain whether KEY advice had been followed. Community and health professional support was strong; 99% of participants rated involvement as beneficial. Of 402 high-risk individuals recruited, findings were suggestive of CKD in 20.4%. Of these, 69% had hypertension, 30% diabetes, and 40% elevated total cholesterol. All participants with CKD stage 3b or higher were aged >61 years. Overall, 58% of participants were referred to their primary care providers for further action; of these, 82% saw their doctors in the next 3 months and 94% discussed KEY results. Follow-up telephone contact was successful for 82% of participants. A change in management occurred for 67%. Thus, the KEY approach to early detection of CKD and selected referral of participants was largely successful.

Entities:  

Mesh:

Year:  2010        PMID: 20186177     DOI: 10.1038/ki.2009.538

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  13 in total

1.  Estimated GFR reporting influences recommendations for dialysis initiation.

Authors:  K Scott Brimble; Rajnish Mehrotra; Marcello Tonelli; Carmel M Hawley; Clare Castledine; Stephen P McDonald; Vicki Levidiotis; Azim S Gangji; Darin J Treleaven; Peter J Margetts; Michael Walsh
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

Review 2.  Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review.

Authors:  Pankti A Gheewala; Syed Tabish R Zaidi; Matthew D Jose; Luke Bereznicki; Gregory M Peterson; Ronald L Castelino
Journal:  J Nephrol       Date:  2017-02-08       Impact factor: 3.902

3.  Detection of urinary abnormalities in a community from northern Italy based on the World Kidney Day screening program.

Authors:  F Fabbian; P L Bedani; E Rizzioli; C Molino; M Pala; A De Giorgi; C Longhini; F Portaluppi
Journal:  Int Urol Nephrol       Date:  2010-11-04       Impact factor: 2.370

4.  Point-of-Care Testing and Creatinine Measurement.

Authors:  Mark Ds Shephard
Journal:  Clin Biochem Rev       Date:  2011-05

5.  Cystatin C, mortality risk and clinical triage in US adults: threshold values and hierarchical importance.

Authors:  Robert N Foley; Changchun Wang; Allan J Collins
Journal:  Nephrol Dial Transplant       Date:  2010-10-20       Impact factor: 5.992

Review 6.  Dialysis-treated end-stage kidney disease in Libya: epidemiology and risk factors.

Authors:  Fathea Abobker Goleg; Norella Chiew-Tong Kong; Ramesh Sahathevan
Journal:  Int Urol Nephrol       Date:  2014-03-27       Impact factor: 2.370

Review 7.  CKD Screening and Surveillance in Australia: Past, Present, and Future.

Authors:  Sree K Venuthurupalli; Wendy E Hoy; Helen G Healy; Anne Cameron; Robert G Fassett
Journal:  Kidney Int Rep       Date:  2017-10-06

8.  Public knowledge of chronic kidney disease evaluated using a validated questionnaire: a cross-sectional study.

Authors:  Pankti A Gheewala; Gregory M Peterson; Syed Tabish R Zaidi; Matthew D Jose; Ronald L Castelino
Journal:  BMC Public Health       Date:  2018-03-20       Impact factor: 3.295

Review 9.  The Landscape of Diabetic Kidney Disease in the United States.

Authors:  O Kenrik Duru; Tim Middleton; Mona K Tewari; Keith Norris
Journal:  Curr Diab Rep       Date:  2018-02-19       Impact factor: 4.810

10.  Australian Community Pharmacists' Experience of Implementing a Chronic Kidney Disease Risk Assessment Service.

Authors:  Pankti A Gheewala; Gregory M Peterson; Syed Tabish R Zaidi; Matthew D Jose; Ronald L Castelino
Journal:  Prev Chronic Dis       Date:  2018-06-14       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.